Global Sepsis Diagnostics Market, By Techniques (Immunoassay, Molecular Diagnostic, Microbiology & Flow Cytometry), Test Type (Laboratory Testing & Point of Care Testing) Industry Trends and Forecast to 2029.
Global Market Analysis and Insights : Global Sepsis Diagnostics Market
Sepsis is a potentially life-threatening condition that occurs when the body's response to an infection damages its own tissues. When the infection-fighting processes turn on the body, they cause organs to function poorly and abnormally. Sepsis may progress to septic shock. This is a dramatic drop in blood pressure that can lead to severe organ problems and death. To be diagnosed with sepsis, it is must to confirm the infection with signs such as change in mental status, systolic blood pressure, respiratory rate. Most often, sepsis occurs in people who are hospitalized or who have recently been hospitalized. People in an intensive care unit are more likely to develop infections that can then lead to sepsis. For the diagnosis of sepsis along with blood test other lab test needs to be done. Blood samples are used to test for evidence of infection, clotting problems, abnormal liver or kidney function, impaired oxygen availability, electrolyte imbalances. People who have sepsis require close monitoring and treatment in a hospital intensive care unit. Lifesaving measures may be needed to stabilize breathing and heart function.
Data Bridge Market Research analyses that the market is growing with a CAGR of 8.0% in the forecast period of 2022 to 2029.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2019-2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Techniques (Immunoassay, Molecular Diagnostic, Microbiology & Flow Cytometry), Test Type (Laboratory Testing & Point of Care Testing)
|
|
Countries Covered
|
U.S. and Rest of North America in North America, Germany, France, U.K. and Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Brazil and Rest of South America as part of South America. South Africa, Saudi Arabia and Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
|
|
Market Players Covered
|
The major companies which are dealing in the market are Trinity Biotech (Ireland), Meridian Bioscience (U.S.), Omega Diagnostics Group PLC. (U.K.), Xcyton Diagnostics Limited (india), Diasorin S.p.A (Italy), Seegene Inc. (South Korea), EKF Diagnostics Holdings plc (U.K.), Axis-Shield Diagnostics Ltd. (U.K.), Immunexpress Inc. (U.S.), Luminex Corporation (U.S.), bioMérieux SA (France), BD (U.S.), Thermo Fisher Scientific Inc.(U.S.), Abbott (U.S), Roche Diagnostics (U.S), Cepheid (U.S.), Beckman Coulter, Inc. (U.S.), T2 Biosystems, Inc. (U.S.), Bruker (U.S.) and Ortho Clinical Diagnostics (U.S.).
|
Sepsis Diagnostics Market Dynamics
Drivers
- Rising incidence of hospital-acquired infections
With the rapid increase in HAIs worldwide, there is an increase in the demand for proper sepsis diagnostic products will increase in upcoming years. Therefore, rising incidences of hospital-acquired infections are expected to act as a driver for the growth of the sepsis diagnostics market.
- Rising healthcare expenditure
Another significant factor influencing the growth rate of sepsis diagnostics market is the rising healthcare expenditure which helps in improving its infrastructure.
- Growing prevalence of sepsis
Growing prevalence of sepsis in various regions worldwide and various infections associated with it are expected to act as drivers for the growth of the sepsis diagnostics market
Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the sepsis diagnostics market.
Opportunities
- Evolution of novel biomarkers for sepsis diagnosis
Sepsis is one of the leading causes of mortality and morbidity, even with the current availability of extended-spectrum antibiotics and advanced medical care. Biomarkers offer a tool in facilitating early diagnosis, in identifying patient populations at high risk of complications, and in monitoring the progression of the disease, which are critical assessments for appropriate therapy and improvement in patient outcomes.
Also, the launch of effective therapies and continuous clinical trials will provide beneficial opportunities for the sepsis diagnostics market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate sepsis diagnostics market in future.
Restraints/Challenges
However, high cost of diagnosis and lack of appropriate testing for sepsis will impede the growth rate of sepsis diagnostics market. Additionally, lack of awareness about sepsis will further challenge the market in the forecast period mentioned above.
This sepsis diagnostics market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sepsis diagnostics market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post COVID-19 Impact on Sepsis Diagnostics Market
The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to health-care facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in sepsis medication adherence during the pandemic.
Recent Development
- In May 2020, Beckman Coulter announced the availability of its DxH 690T hematology analyzer in the U.S. which is used as the early sepsis indicator. This announcement has helped company to increase its global presence and growth in the revenue as well.
Global Sepsis Diagnostics Market Scope
The Global sepsis diagnostics market is segmented into techniques and test type. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.
Techniques
- Immunoassay
- Molecular Diagnostic
- Microbiology
- Flow Cytometry
On the basis of techniques, the global sepsis diagnostics market is segmented into microbiology, molecular diagnostic, immunoassay, and flow cytometry.
Test Type
- Laboratory Testing
- Point of Care Testing
On the basis of test type, the global sepsis diagnostics market is segmented into laboratory testing and point of care testing.
Sepsis Diagnostics Market Regional Analysis/Insights
The sepsis diagnostics market is analysed and market size insights and trends are provided by country, techniques and test type as referenced above.
The countries covered in the sepsis diagnostics market report are U.S., rest of North America, Germany, U.K., France, rest of Europe, China, India, Japan, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, rest of Asia-Pacific, Brazil, Rest of South America, Saudi Arabia, South Africa, rest of Middle East and Africa.
North America dominates the sepsis diagnostics market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players and well-developed healthcare infrastructure in this region combined with rising number of the adult population getting diagnosed positive for sepsis, each year in the region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period due to the increasing healthcare expenditure by the government of developing nations and growing government support.
The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Sepsis Diagnostics Market Share Analysis
The sepsis diagnostics market competitive landscape provides details by the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on sepsis diagnostics market.
Some of the major players operating in the sepsis diagnostics market are Trinity Biotech (Ireland), Meridian Bioscience, Omega Diagnostics Group PLC., Xcyton Diagnostics Limited, Diasorin S.p.A, Seegene Inc., EKF Diagnostics Holdings plc., Axis-Shield Diagnostics Ltd., Immunexpress Inc., Luminex Corporation, bioMérieux SA, BD, Thermo Fisher Scientific Inc. Abbott, Roche Diagnostics, Cepheid, Beckman Coulter, Inc., T2 Biosystems, Inc., and Bruker Ortho Clinical Diagnostics among others.
Research Methodology: Global Sepsis Diagnostics Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In adition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
SKU-